Dengue Tetravalent Vaccine (Live, Attenuated) Takeda

Dengue Tetravalent Vaccine (Live, Attenuated) by Takeda is designed to protect against dengue fever. This subcutaneous vaccine targets all four dengue virus serotypes, offering broad coverage.

The Dengue Tetravalent Vaccine is used to prevent dengue fever, a mosquito-borne viral infection. It is administered to individuals at risk of exposure to the dengue virus, providing immunity against all four serotypes. This vaccine is particularly relevant in regions where dengue is endemic.

Common effects of the Dengue Tetravalent Vaccine may include mild fever, headache, and injection site reactions. These effects are typically mild and short-lived, indicating the body's response to the vaccine.

This vaccine should be administered with caution in individuals with weakened immune systems or those allergic to any of its components. Pregnant women and individuals with a history of severe allergic reactions should consult a healthcare provider before vaccination.

The Dengue Tetravalent Vaccine may interact with other live vaccines, potentially reducing their effectiveness. It is advisable to space out the administration of other live vaccines. Always inform your healthcare provider about any medications or vaccines you are currently taking.